Euclidean Technologies Management, LLC Eagle Pharmaceuticals, Inc. Transaction History

Euclidean Technologies Management, LLC

  • $109 Million
  • Q1 2023

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023
BUY
$24.98 - $39.77 $249,800 - $397,700
10,000 Added 16.06%
72,263 $2.11 Million
Q3 2022

Oct 28, 2022
BUY
$26.42 - $47.12 $1.64 Million - $2.93 Million
62,263 New
62,263 $1.65 Million

Others Institutions Holding EGRX

# of Institutions
70
Shares Held
8.6M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Euclidean Technologies Management, LLC Portfolio

Follow Euclidean Technologies Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Euclidean Technologies Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Euclidean Technologies Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email